Prevalence and Characterization of Persistent Dyspnea After Hospitalization (DyHP)

July 22, 2021 updated by: Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil

Prevalence and Characterization of Persistent Dyspnea After an Hospitalization for a Respiratory Disease

The investigators aim to make an overview of persistent dyspnea at the end of an hospitalization for a respiratory disease using an actual tool, the Multidisciplinary Dyspnea Profile questionnaire.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Every consecutive patient admitted to hospitalization for a respiratory cause having a significant dyspnea

Description

Inclusion Criteria:

  • Age over 18 years old
  • Able to respond the questionnaire
  • Presenting at admission a dyspnea over 3/10 on numerical analogic scale
  • Admitted for a respiratory cause

Exclusion Criteria:

  • cognitive impairment
  • aphasia
  • no french-speaking person

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Prevalence of persistent dyspnea in the end of an hospitalization for a a respiratory disease
Time Frame: An average of one week, until the end of the hospitalization
An average of one week, until the end of the hospitalization

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Characterization of persistent dyspnea using MDP
Time Frame: An average of one week, until the end of the hospitalization
An average of one week, until the end of the hospitalization
Outcome of patients with persistent dyspnea after hospitalization
Time Frame: 6 months
6 months mortality, incidence of rehospitalization
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Association pour le Développement et l'Organisation de la Recherche en Pneumologie et sur le Sommeil

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 11, 2019

Primary Completion (Anticipated)

April 30, 2025

Study Completion (Anticipated)

April 30, 2025

Study Registration Dates

First Submitted

November 21, 2018

First Submitted That Met QC Criteria

January 8, 2019

First Posted (Actual)

January 9, 2019

Study Record Updates

Last Update Posted (Actual)

July 23, 2021

Last Update Submitted That Met QC Criteria

July 22, 2021

Last Verified

July 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2018-A02757-48

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pulmonary Disease

Clinical Trials on Multidisciplinary Dyspnea Profile questionnaire

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in China

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe